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Abstract

Author Manuscript

Breast cancer is a leading cause of morbidity and mortality in women. Both Epidemiological and
experimental studies indicate a positive correlation between alcohol consumption and the risk of
breast cancer. While alcohol exposure may promote the carcinogenesis or onset of breast cancer, it
may as well enhance the progression and aggressiveness of existing mammary tumors. Recent
progress in this line of research suggests that alcohol exposure is associated with invasive breast
cancer and promotes the growth and metastasis of mammary tumors. There are multiple potential
mechanisms involved in alcohol-stimulated progression and aggressiveness of breast cancer.
Alcohol may increase the mobility of cancer cells by inducing cytoskeleton reorganization and
enhancing the cancer cell invasion by causing degradation and reconstruction of the extracellular
matrix (ECM). Moreover, alcohol may promote the epithelial-mesenchymal transition (EMT), a
hallmark of malignancy, and impair endothelial integrity, thereby increasing the dissemination of
breast cancer cells and facilitating metastasis. Furthermore, alcohol may stimulate tumor
angiogenesis through the activation of cytokines and chemokines which promotes tumor growth.
Additionally, alcohol may increase the cancer stem cell population which affects neoplastic cell
behavior, aggressiveness, and the therapeutic response. Alcohol can be metabolized in the
mammary tissues and breast cancer cells which produces reactive oxygen species (ROS), causing
oxidative stress. Recent studies suggest that the epidermal growth factor receptor (EGFR) family,
particularly ErbB2 (a member of this family), is involved in alcohol-mediated tumor promotion.
Breast cancer cells or mammary epithelial cells over-expressing ErbB2 are more sensitive to
alcohol’s tumor promoting effects. There is considerable cross-talk between oxidative stress and
EGFR/ErbB2 signaling. This review further discusses how the interaction between oxidative stress
and EGFR/ErbB2 signaling contributes to the cellular and molecular events associated with breast
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cancer aggressiveness. We also discuss the potential therapeutic approaches for cancer patients
who drink alcoholic beverages.

Graphical abstract
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1. Introduction

Author Manuscript

Breast cancer is a leading cause of morbidity and mortality in women [1, 2]. Although the
exact etiology of breast cancer is unclear, nutrition and life style have been considered
important contributing factors [3, 4]. Heavy alcohol consumption has devastating health
effects and is associated with many maladies such as infectious diseases, cancer, digestive
diseases, diabetes, neuropsychiatric diseases, cardiovascular disease, liver and pancreatic
disease [5]. It is now well-established that alcohol consumption is a risk factor for breast
cancer [6–13]. Upon careful evaluation, it appears that alcohol may not only increase the
risk, but also promote the malignancy of existing mammary tumors; that is, alcohol may
promote both onset/carcinogenesis and progression/prognosis.

Author Manuscript

For the onset/carcinogenesis of mammary tumors, there are several potential contributing
mechanisms. First, alcohol exposure may cause DNA damage and gene mutation. Although
alcohol per se is not a direct carcinogen, acetaldehyde, a product of alcohol metabolism, is a
mutagen which can form adducts with protein and DNA, inducing gene mutation, DNA
crosslinks and chromosomal aberrations [9, 14–18]. Alcohol dehydrogenase (ADH), a key
enzyme of alcohol metabolism, is expressed in the human breast epithelial cells; therefore
the human mammary tissue has the capacity to metabolize alcohol [9]. Due to limited ability
to detoxify acetaldehyde in the mammary tissue, acetaldehyde accumulates for prolonged
periods, which enhances its toxicity [9]. It is proposed that alcohol exposure induces
mammary carcinogenesis through the production of acetaldehyde [19]. Second, alcohol may
promote mammary carcinogenesis by altering circulating sex hormone levels. Sex
hormones, such as estrogen, play an important role in the etiology of breast cancer.
Perturbed estrogen levels and increased expression and activity of estrogen receptor α (ERα) are identified upon chronic alcohol consumption [9, 17, 20–23]. Third, alcohol-induced
Pharmacol Res. Author manuscript; available in PMC 2018 January 01.
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dysregulation of epigenetic regulation of gene expression, particularly abnormal DNA
methylation may also contribute to mammary carcinogenesis, because epigenetic
dysregulation is a key mechanism for tumor initiation and progression [9, 24]. Forth, alcohol
may promote the carcinogenesis by disrupting the homeostasis of growth factors and
nutrient status, such as IGF1 and vitamins [19, 25–27]. In addition to its carcinogenic effect,
alcohol abuse is associated with advanced and invasive breast cancer [28–31], suggesting
that alcohol may promote the progression of existing tumors and induce more aggressive
phenotypes. Indeed, a number of recent experimental studies support this hypothesis and
show that alcohol enhances the aggressiveness and malignancy of breast cancer [32–34].
Although alcohol-mediated carcinogenesis and progression/aggressiveness could share some
common causes, distinct mechanisms may operate. A better understanding of these
mechanisms is critical in developing effective therapeutic strategies for breast cancer
patients who drink alcoholic beverages. This review will discuss the recent progress in this
line of research.
Experimental studies clearly demonstrate that alcohol alters the behavior of breast cancer
cells and changes them to more aggressive phenotypes. We will first review the effect of
alcohol on cellular events and processes associated with cancer aggressiveness and
malignancy, and then discuss the potential underlying cellular/molecular mechanisms.

2. Alcohol-induced aggressiveness of breast cancer
2.1. Alcohol promotes migration/invasion, growth and metastasis of breast cancer cells

Author Manuscript

Cancer metastasis is the spread of cancer cells to tissues and organs beyond where the tumor
originated and the formation of new tumors. The metastatic cascade can be separated into
three main processes: invasion, intravasation, and extravasation. The process of invasion
involves the loss of cell-cell adhesion capacity which allows malignant tumor cells to
dissociate from the primary tumor mass and invade the surrounding stroma. Intravasation is
the invasion of cancer cells through the basal membrane into a blood or lymphatic vessel.
This process enables cells to enter the circulatory system and metastasize to distant sites.
The process of extravasation occurs when the tumor cells have arrived at the destination,
they penetrate the endothelium and the basement membrane, forming new tumors.

Author Manuscript

Using Boyden chamber and wound healing assays, the data from our laboratory and others
consistently show that alcohol enhances the migration of breast cancer cells [32, 33, 35–38].
Alcohol-induced mobility may result from the interaction with the extracellular matrix
(EMC) and reorganization of the cytoskeleton system [38, 39]. Alcohol also increases the
invasive potential of breast cancer cells [37, 40–42]. The increased invasion is likely
mediated by the enhanced ability of breast cancer cells to degrade the EMC, in which matrix
metalloproteinases (MMPs) play an important role [40, 41]. Alcohol-stimulated migration/
invasion is further demonstrated in a 3-dimension (3-D) Matrigel system [32, 33]. The
aggressive breast cancer cells have a property to grow to scattering spheroids in the 3-D
culture system. We show that alcohol exposure significantly increases the spreading of
breast cancer cells in this 3-D system. More importantly, after chronic exposure to alcohol,
less aggressive breast cancer cells are transformed into a more aggressive phenotype which
is demonstrated by the scattering spheroids in the 3-D culture system [32, 33]. In some
Pharmacol Res. Author manuscript; available in PMC 2018 January 01.
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studies, alcohol is shown to promote the growth of breast cancer cells both in vitro and in
vivo [21–23, 43–45]. Alcohol-induced increase in the growth of breast cancer cells may
result from either enhanced cell proliferation or promotion of survival. Animal studies
confirm that alcohol consumption not only promotes the growth but also the metastasis of
breast cancer cells to the lung and colon in mice [32, 33, 43, 44]. MMTV-neu transgenic
mice are extensively used for the study of the tumorigenesis and progression of breast
cancer. These mice express neu oncogene (homology to human ERBB2) under the
transcriptional control of the mouse mammary tumor virus promoter/enhancer and develop
spontaneous mammary tumors. Chronic alcohol consumption significantly promotes the
metastasis of breast cancer cells to the lung and colon (Fig. 1) [33].
2.2. Alcohol disrupts extracellular matrix (ECM), endothelial integrity, and promotes
epithelial- mesenchymal transition (EMT)

Author Manuscript
Author Manuscript

One of the key functions of MMPs is to degrade the ECM, a critical step for the
intravasation and extravasation. MMPs play an important role in the malignancy of
mammary tumors [46]. MMP2 and MMP9 are two typical collagenases secreted by tumor
cells or stromal cells that catalyze the destruction of the surrounding ECM. It has been
demonstrated that alcohol can promote the degradation of the ECM by activating MMPs.
Etique et. al. [47] show that alcohol stimulates the secretion of MMP2 and MMP9 from
breast cancer cells. In our studies, alcohol activates MMP2 in breast cancer cells by
promoting the cleavage of the pro-enzyme and transferring to an active enzyme. Knocking
down of MMP2 with small interference RNA or selective inhibitors partially blocks alcoholstimulated cell invasion [41]. Interestingly, alcohol can also stimulate the secretion and
activation of MMP2 from stromal fibroblast cells which are a major cell type expressing
MMP2 [40]. Moreover, the activation of fibroblast-derived MMP2 significantly contributes
to the invasive phenotype of breast cancer induced by alcohol exposure [40]. Different from
the report by Etique et al. [47], our studies show that alcohol selectively activates MMP2 but
not MMP9 in mammary epithelial cells or fibroblasts [40, 41].

Author Manuscript

Another potential mechanism for alcohol promotion of cancer metastasis is to disrupt the
endothelial integrity which facilitates the intravasation and extravasation. Alcohol-induced
disruption of endothelial integrity is evident by the decrease of electric resistance across the
endothelial monolayer and the appearance of an intercellular gap among endothelial cells
[48]. The effect of alcohol is reversible once alcohol is removed. The disruption of the
endothelial monolayer integrity was associated with an increased invasion of cancer cells
through the endothelial monolayer. It appears the alcohol-induced disruption of endothelial
integrity is caused by damaged adherens junctions resulting from the endocytosis of VEcadherin [48]. The epithelial–mesenchymal transition (EMT) is a developmental program
but also plays an important role in cancer progression and metastasis. Studies suggest that
alcohol can promote EMT phenotypic change and enhance aggressiveness of breast cancer.
For example, vimentin, as a marker of mesenchymal cells or cells undergoing EMT, is
upregulated by alcohol in breast cancer cells; conversely, E-cadherin, a hallmark for
epithelial cells, is downregulated in breast cancer cells [49]. Other characteristics of EMT,
such as increased expression of MMPs (MMP2, MMP7 and MMP9) and decreased
expression of α-, β-, and γ-catenin are observed in breast cancer cells following alcohol
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exposure [36, 41, 49]. Snail is a key regulator of EMT and alcohol increases the expression
and phosphorylation of Snail through stimulating EGFR signaling [49]. Together, these
results suggest that alcohol may induce the EMT in breast cancer cells.
2.3. Alcohol enhances tumor angiogenesis

Author Manuscript

Angiogenesis in tumor tissues is an essential process for cancer growth and metastasis.
Several studies consistently show that alcohol promotes tumor angiogenesis [39, 43, 44, 50,
51]. A number of mechanisms have been proposed for alcohol-induced angiogenesis; these
include enhanced endothelial cell proliferation and migration, promotion of cancer/
endothelial cell interaction and alterations of tumor microenvironment. An in vitro study
shows that alcohol can directly target endothelial cells and cause actin filament
reorganization, resulting in enhanced migration and tube formation of endothelial cells [39].
Using a 3-D endothelial cell/breast cancer cell co-culture system, we show that alcohol
significantly increases the angiogenesis in the presence of cancer cells [43, 44]. The effect of
alcohol is likely mediated by the stimulation of vascular endothelial growth factor (VEGF)
and monocyte chemoattractant protein-1 (MCP-1) signaling. VEGF is a key regulator of
angiogenesis. Alcohol upregulates the expression of VEGF and its receptor Flt-1 in mice;
inhibiting VEGF-mediated signaling partially blocks alcohol-stimulated angiogenesis and
tumor growth [44, 51]. MCP-1, also called chemokine (CC motif) ligand 2 (CCL2), is a proinflammatory chemokine, acting as a potent chemoattractant for monocytes and
macrophages. Alcohol increases expression of MCP-1 and its receptor CCR2 in both
mammary tumor tissues and breast cancer cells in vitro and in vivo [43]. CCR2 antagonist
significantly inhibits alcohol-induced tumor angiogenesis and mammary tumor growth in
mice [43].

Author Manuscript

2.4. Alcohol increases the cancer stem-like cells (CSCs) population in breast cancer cells

Author Manuscript

Breast cancers display considerable phenotypic and genetic heterogeneity. Cancer stem cells
(CSCs), a subpopulation of cancer cells with self-renewal and differentiation capacity, play
an important role in tumor initiation, progression, metastasis, recurrence, and therapy
resistance [52, 53]. The recent evidence from both in vitro and in vivo studies suggests that
alcohol may increase the CSC population in breast cancer. We show that alcohol exposure
causes a drastic increase in the CSC population and mammosphere formation in breast
cancer cells overexpressing ErbB2 and in MMTV-neu mice (Fig. 2) [33]. In breast cancer
cells with low levels of ErbB2, the CSC population is relatively small. These cells are
relatively insensitive to acute alcohol exposure. However, long term treatment of alcohol
also significantly increases the CSC population in these cells, which is accompanied by an
increase in cell migration/invasion, anchorage-independent colony formation and scattering
spheroids in a 3-D Matrigel system [32]. The findings are confirmed by the animal studies
which show that chronic alcohol exposure increases CSCs in the mammary tumors of
MMTV-neu transgenic mice [33].
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3. Cellular and molecular mechanisms underlying alcohol-induced cancer
aggressiveness
3.1. Role of oxidative stress in alcohol-promoted breast cancer aggressiveness

Author Manuscript

3.1.1. Alcohol-induced reactive oxygen species (ROS) and oxidative stress in
mammary tissues and breast cancer cells—Excessive ROS accumulation and
oxidative stress have been proposed as important mechanisms for mammary carcinogenesis
and aggressiveness [54]. Alcohol-induced ROS and oxidative stress may be mediated by
alcohol metabolism, damaged mitochondria, and an antioxidant response [55]. Alcohol is
first oxidized to acetaldehyde in cytosol by alcohol dehydrogenase (ADH). Acetaldehyde is
transported into the mitochondria and rapidly metabolized to acetate by aldehyde
dehydrogenase 2 (ALDH2). In the mitochondria, acetate is converted to acetyl-CoA, which
enters the citric acid cycle for ultimate oxidization. In both ADH and ALDH2 catalyzed
reactions, NAD+, is used as an electron carrier to form NADH, which is eventually
transported into the mitochondria for ATP production. Depending on oxygen supply and the
demand of ATP, NADH may not be efficiently oxidized, which causes electrons to be
diverted to form ROS, causing oxidative stress [55]. During chronic alcohol consumption or
in tissues that lack ADH, cytochrome P450 2E1 (CYP2E1) is induced to engage in alcohol
metabolism, which concomitantly oxidizes NADPH to generate ROS. Alternatively, alcohol
can activate NADPH oxidase (NOX) which produces ROS [56]. Alcohol-metabolizing
enzymes such as cytochrome CYP2E1, ADH and xanthine oxidoreductase (XOR), and NOX
are expressed in mammary tissues and breast cancer cells, indicating alcohol can be
metabolized in mammary tissues [57–63].

Author Manuscript

ROS mainly comprises four species including superoxide anion, hypochlorite ion, hydroxyl
radicals, and hydrogen peroxide. They are highly active and interact with lipid, protein, and
DNA. Using electron spin resonance (ESR), we demonstrate that alcohol is able to generate
a whole spectrum of ROS in mammary epithelial cells and breast cancer cells [38, 64].
Alcohol also promotes ROS production and oxidative stress in breast cancer-associated
stromal fibroblasts [65]. It appears that CYP2E1 is involved in alcohol-induced ROS
production in mammary epithelial cells; the alcohol-induced ROS in turn activates the
epidermal growth factor receptor (EGFR) [66]. Other evidence shows that alcohol exposure
may cause oxidative stress by down-regulation of detoxification enzymes in mammary
epithelial cells, which results in decreased clearance of ROS [67].

Author Manuscript

3.1.2.The role of ROS in alcohol-induced aggressiveness of breast cancer
cells—ROS is involved in alcohol-stimulated migration/invasion of breast cancer cells,
because scavenging alcohol-induced ROS production by antioxidants significantly inhibits
alcohol-induced migration and invasion [38, 41, 64]. ROS also plays a role in alcoholinduced MMP2 activation; antioxidants abrogate alcohol-induced MMP2 activation and
inhibit the alcohol-stimulated invasion in mammary epithelial cells overexpressing ErbB2
[41, 68]. It appears that ROS mediates alcohol-induced breast cancer cells/ECM interaction
and cell mobility. Cyanidin-3-glucoside (C3G), an anthocyanin present in many vegetables
and fruits, is a potent natural antioxidant. We show that C3G decreases alcohol-mediated cell
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adhesion to the ECM as well as the amount of focal adhesions and the formation of
lamellipodial protrusion [38].
It is well established that ROS promotes EMT in mammary epithelial or breast cancer cells
through diverse mechanisms [69, 70]. It is suggested that the activation of EGFR is involved
in alcohol-promoted EMT [49] and alcohol may activate EGFR through intracellular ROS
accumulation [66]. However, more direct evidece is required to draw a conclusion regrading
the role of ROS in alcohol-promoted EMT.

Author Manuscript

ROS is long known for being involved in tumor angiogenesis [54, 71–74]. It is generally
accepted that low levels of ROS promote angiogenesis whereas high levels of ROS may have
the opposite effect. ROS regulation of angiogenesis is mainly mediated by VEGF signaling
[75, 76]. But ROS can also promote angiogenesis in a VEGF independent manner [77, 78].
We have previously shown that alcohol-induced ROS can directly promote the tube
formation of endothelial cells [39]. We have also demonstrated that alcohol promotes
angiogenesis in mammary tumors by stimulating MCP-1 signaling [43] and it is likely that
alcohol-induced activation of MCP-1 is mediated by ROS [79].

Author Manuscript

In addition to promoting angiogenesis, alcohol-induced ROS may disrupt endothelial
integrity, consequently increasing the permeability of blood vessels. We demonstrate that
alcohol causes a reversible disruption of the endothelial barrier and an enhanced invasion of
cancer cells through the endothelial monolayer [48]. Vascular endothelial cadherin (VEcadherin), a major component of endothelial adherens junctions, plays many functional roles
in regulating endothelial barrier integrity. VE-cadherin is linked to the actin cytoskeleton
through β- and α-catenin. The stabilization of the cadherin/catenin complex maintains
endothelial integrity and inhibits tumor cell intravasation and extravasation. We show that
alcohol inhibits VE-cadherin/β-catenin association and disrupts the endothelial barrier [48].
Since ROS can cause phosphorylation of the VE-cadherin and thereby result in disassembly
of VE-cadherin/catenin complex and the breakdown of intercellular connections [80–82],
the effect of alcohol on endothelial integrity may be mediated by ROS production.
3.2. Role of epidermal growth factor receptor (EGFR) family in alcohol-promoted breast
cancer aggressiveness

Author Manuscript

3.2.1. The EGFR and ErbB2 signaling pathways in breast cancer—The EGFR
family is comprised of four structurally similar receptors including EGFR (ErbB1 or HER1),
ErbB2 (HER2), ErbB3 (HER3) and ErbB4 (HER4) [83, 84]. They are type I transmembrane kinase receptors, which upon ligand binding in the extracellular domain, undergo
dimerization and subsequent trans-phosphorylation in the intracellular domain. EGFR and
ErbB2 receive particular attention in the context of breast cancer etiology and therapy
because of their frequent overexpression and hyperactivation in breast carcinomas [83].
Overexpression of EGFR and ErbB2 is associated with malignant breast cancers, increased
metastasis, and poor prognosis [84–88].
EGFR is activated by a number of ligands including EGF, amphiregulin, transforming
growth factor alpha (TGFα), neuregulin 2β, betacellulin, heparin-binding EGF-like growth
factor, and epiregulin [84, 89]. So far there is no identified ligand for ErbB2; the activation
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of ErbB2 is mediated through heterodimeric partners, e.g., EGFR, ErbB3 ErbB4 [85]. Upon
activation, EGFR and ErbB2 trigger several important signaling cascades that play a key role
in the carcinogenesis and aggressiveness of breast cancer, such as MAPK, PI3K/AKT/
mTOR, Src, JAK/STAT3, PLC-γ/PKC and GSK3β/β-catenin [84, 88, 90–93]. The activation
of these signaling cascades frequently promotes the proliferation, migration/invasion,
growth, and metastasis of breast cancer [84].

Author Manuscript

3.2.2. EGFR and ErbB2 signaling in alcohol-promoted aggressiveness of
breast cancer—It has been proposed that EGFR may mediate some of alcohol’s tumor
promoting effects [94]. Alcohol stimulates the phosphorylation of EGFR in mammary
epithelial cells [66]. Snail, a transcriptional activator of EMT markers, is upregulated by
alcohol in an EGFR-dependent manner [49]. Alcohol-induced migration of breast cancer
cells is blocked by AG1478, an EGFR inhibitor [49]. Together, the evidence indicates that
the activation of EGFR is involved in alcohol-promoted aggressiveness of breast cancer.
There are several potential mechanisms underlying alcohol activation of EGFR; these
include stimulation of EGFR phosphorylation by ROS, an increase in the expression of
ligands for EGFR, and inhibition of phosphatases that regulate the dephosphorylation of
EGFR [94].

Author Manuscript

More studies indicate the interaction between alcohol and ErbB2. Generally, there is a
positive correlation between the expression level of ErbB2 and the sensitivity of breast
cancer cells to alcohol-elicited migration/invasiveness. In a study we investigated the effect
of alcohol on various breast cancer cell lines [35, 64]. For all human breast cancer cells and
mammary epithelial cells examined, alcohol drastically increased the migration/invasion of
cells overexpressing ErbB2, but only had a modest or little effect on cells with low ErbB2
expression. For breast cancer and mammary epithelial cells that are less responsive to
alcohol, artificial overexpression of ErbB2 enhances their sensitivity to alcohol and
potentiates alcohol-stimulated cell migration/invasion [64]. Alcohol up-regulates the
expression of ErbB2, ErbB3 and ErbB4, but not ErbB1 in human breast cancer cells (T47D)
[35]. Heregulin β1 (ligand for ErbB3 and ErbB4) synergizes the alcohol-stimulated invasion
of T47D [35]. Knocking down ErbB2 with an anti-sense oligonucleotide eliminates
heregulin β1- and alcohol-promoted cell migration/invasion [35], supporting the conclusion
that ErbB2 is involved in alcohol-stimulated migration/invasion of breast cancer cells. The
enhanced sensitivity of breast cancer cells overexpressing ErbB2 may be mediated by
alcohol-induced activation of ErbB2. We show that alcohol stimulates the phosphorylation
of ErbB2 and its interaction with downstream effectors, such as cSrc and FAK (Fig. 3) [37].

Author Manuscript

In addition to migration/invasion, alcohol-induced MMP2 activation is also dependent on the
expression of ErbB2 [41]. Both clinical and experimental data suggest that ErbB2 may
regulate MMP production in breast cancer cells [41, 95]. The activation of ErbB2 signaling
increases MMP2 and MMP9 production through p38 MAPK and PI3K pathways [41].
Alcohol drastically activates MMP2 in mammary epithelial cells that over-express ErbB2,
but has little effect on cells with low ErbB2 expression [41]. Furthermore, alcohol-induced
interaction of breast cancer cells with the ECM, such as cell adhesion to the fibronectin, is
also likely mediated by ErbB2 [37, 38]. The in vitro observation is supported by animal
studies which show that chronic alcohol consumption enhances ErbB2 signaling in MMTVPharmacol Res. Author manuscript; available in PMC 2018 January 01.
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neu mice and promotes the metastasis of breast cancer cells to the lung and colon (Fig 1)
[33]. In addition, one study investigates the effect of prenatal alcohol exposure on the
development of mammary glands and tumorigenesis in MMTV-neu mice. The results
indicate that prenatal alcohol exposure alters the development of mammary glands and
increases multiplicity of breast tumors with high expression of neu (ERBB2) [96].

Author Manuscript

ErbB2 also plays an important role in the alcohol-induced increase of CSC populations [33].
Alcohol exposure causes a drastic increase in the CSC population and mammosphere
formation in breast cancer cells overexpressing ErbB2, but it has a modest effect on breast
cancer cells expressing low levels of ErbB2 [33]. Consistently, alcohol consumption
increases the CSC population and ErbB2 phosphorylation in the mammary tumors of
MMTV-neu mice [33]. Both in vitro and in vivo studies indicate that alcohol significantly
increases the phosphorylation of ErbB2 in breast cancer cells and mammary epithelial cells
expressing high levels of ErbB2, but has little effect on cells with low levels of ErbB2 [33,
37, 64]. Together, these studies confirm the idea that alcohol induces ErbB2 activation and
results in more aggressive neoplastic behavior.

Author Manuscript

3.2.3. Down-stream signaling of EGFR and ErbB2 in alcohol-induced
aggressiveness of breast cancer—As discussed above, a number of signaling
cascades down-stream of EGFR and ErbB2 may be involved in alcohol-induced
aggressiveness of breast cancer, such as MAPK, PI3K/AKT/mTOR, Src, JAK/STAT3, PLCγ/PKC and GSK3β/β-catenin. Alcohol activates three members of MAPKs, namely,
extracellular signal regulated kinase (ERK), c-Jun NH2 terminal protein kinase (JNK1/2)
and p38 mitogen-activated protein kinase (p38 MAPK) in an ErbB2-dependent manner [64].
Only the selective inhibitors for JNK1/2 and p38 MAPK but not for PI3K and ERK inhibits
alcohol-induced migration/invasion of breast cancer cells overexpressing ErbB2, indicating
that JNK1/2 and p38 MAPK are involved in alcohol-promoted aggressiveness [64].
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To further analyze the contribution of p38 MAPK to alcohol-promoted aggressiveness of
breast cancer, we examined the effect of alcohol on p38 MAPK isoforms. So far, there are
four p38 MAPK isoforms, p38α, p38β, p38γ and p38δ. We show that alcohol selectively
activates p38γ but not other isoforms in an ErbB2-dependent manner [32]. p38γ is
particularly implicated in breast cancer progression and aggressiveness [97]. We show that
p38γ is down-stream of ErbB2 because inhibition of ErbB2 abolishes alcohol-induced
activation of p38γ and its interaction with the substrate, SAP97/DLG. SAP97/DLG is a
scaffold protein and is involved in cell migration [98, 99]. Moreover, the activation of
ErbB2/p38γ/SAP97/DLG axis appears to mediate an alcohol-induced increase in migration/
invasion as well as CSC because blocking ErbB2 or p38γ significantly inhibits alcoholstimulated migration/invasion and increases CSC population [32].
RhoC, a member of Rho family of GTPase, has been suggested to enhance cell mobility and
metastasis through the degradation and reconstruction of the ECM and induction of
angiogenic factors [100–102]. Our results show that RhoC is a downstream effector of
ErbB2 and p38γ. The alcohol-induced activation of p38γ upregulates RhoC levels by
promoting RhoC stability which results in enhanced migration/invasion [32].
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FAK is a component of focal adhesions and regulates the formation of the focal complex.
ErbB2/ErbB3 signaling has been reported to activate FAK, which leads to oncogenesis and
invasiveness of breast cancer [103]. In addition, it has been suggested that FAK may regulate
the activity of p38 MAPK and JNKs [104, 105]. We show that alcohol-induced activation of
ErbB2 causes the phosphorylation of FAK (Y861) and cSrc (Y216), and promotes the
interaction among them in breast cancer cells overexpressing ErbB2 (Fig. 3) [37].
Functionally, active FAK promotes cell adhesion to fibronectin, an important component of
the ECM. AG825, an inhibitor for ErbB2, inhibits ErbB2 phosphorylation and its association
with FAK, blocking alcohol-promoted formation of focal adhesions [37].

Author Manuscript

GSK3β/β-catenin pathway plays an important role in tumorigenesis and cancer therapy
[106]. We show that alcohol activates this pathway by inhibiting GSK3β, which results in an
increase in the migration/invasion of colon cancer cells [107]. However, the effect of alcohol
on the GSK3β/β-catenin pathway in the context of breast cancer aggressiveness needs to be
further verified.
3.3. The interaction between ROS and EGFR/ErbB2 signaling pathway in response to
alcohol exposure
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As discussed above, both oxidative stress and EGFR/ErbB2-mediated cell signaling play an
important role in alcohol-promoted aggressiveness of breast cancer. There is considerable
interaction between oxidative stress and EGFR/ErbB2. ROS may either activate EGFR/
ErbB2 or directly target their down-stream signaling components [108–110]. This is
supported by the evidence showing that alcohol stimulates the phosphorylation of EGFR and
ErbB2 in mammary epithelial cells and breast cancer cells in a ROS-dependent manner [38,
66]. Cyanidin-3-glucoside (C3G), a potent antioxidant scavenges alcohol-induced ROS
accumulation, blocks alcohol-induced phosphorylation of ErbB2 and the activation of downstream signaling proteins, such as cSrc, FAK and p130Cas [38]. We further demonstrate that
alcohol-induced ROS may activate MMP2 through the conventional PKC pathway in
fibroblasts, which promotes the migration/invasion of breast cancer cells [40].
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On the other hand, the status of EGFR/ErbB2 may also contribute to alcohol-induced
oxidative stress. For example, it appears that high levels of ErbB2 make breast cancer cells
and mammary epithelial cells more susceptible to alcohol-stimulated production of ROS
[64]. In ErbB2 over-expressed cells, alcohol causes more intracellular accumulation of •OH
radicals than in cells with low ErbB2 levels. The high levels of ROS in turn activates ErbB2mediated signaling as well as enzymes that contribute to aggressive behaviors of breast
cancer cells, such as p38γ, FAK, and MMP-2. The mechanisms underlying how ErbB2
contribute to alcohol-induced ROS production remain unclear.

4 Conclusion, potential therapeutic targets, and future studies
The experimental studies support the epidemiological observations that alcohol enhances the
aggressiveness of breast cancer. However, the underlying mechanisms are complex and
likely involved in multiple factors. Available evidence clearly demonstrates that ROS and
EGFR/ErbB2 signaling play an important role in this process. Therefore, the approaches
targeting oxidative stress and EGFR/ErbB2 signaling should be preferentially considered.
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First, scavenging alcohol-induced ROS using natural antioxidants is a practical strategy. For
example, C3G, a potent natural antioxidant rich in many vegetables and fruits, proves to be
very effective in alleviating alcohol-induced oxidative stress in breast cancer cells and
neurons while it has a low cytotoxicity [38, 111]. C3G has been proved to significantly
attenuate alcohol-induced phosphorylation of ErbB2 and migration/invasion of breast cancer
cells. Second, breast cancer cells with high levels of EGFR/ErbB2 appear to be more
sensitive to alcohol. A further analysis of clinical data is necessary to establish the
association of EGFR/ErbB2 status and the aggressiveness of breast cancer in the context of
alcohol consumption. Reagents targeting these receptors, such as erlotinib (Tarceva) and
trastuzumab (Herceptin), should be considered in patients who drink alcoholic beverages.
Since alcohol specifically affects some signaling components and enzymes, such as p38γ
and MMP2, drugs targeting these proteins may alleviate the aggressive behaviors associated
with alcohol consumption. For example, selective inhibition of p38γ is sufficient to
attenuate alcohol-stimulated CSC in breast cancer [33]. The inhibitors targeting MMP2 is
also effective in blocking alcohol-stimulated invasion of breast cancer cells [41]. Third,
targeting alcohol-promoted tumor angiogenesis may also be an important approach. For
example, the growth factor VEGF and chemokine MCP-1 is involved in alcohol-promoted
tumor angiogenesis [43, 44]; blocking VEGF and MCP-1-mediated signaling inhibits
alcohol-induced tumor angiogenesis, growth and metastasis of breast cancer cells. Since
alcohol affects multi-components/cascades involved in tumor progression and
aggressiveness, future experimental studies may need to simultaneously target multiple
components or cascades, which will likely yield more effective therapeutic outcomes
particularly for alcoholic cancer patients. Finally, owing to the evidence that alcohol
increases breast cancer progression, primary care givers should question each breast cancer
patient about her alcohol intake. If the consumption is determined excessive, the patient
should be informed about its consequences and recommend that alcohol intake be prohibited
or reduced.
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Alcohol promotes cancer metastasis and the activation of ErbB2. A: FVB MMTV Neu mice
were fed with liquid diet containing ethanol (0 or 6.7%). After tumors reached a maximal
diameter of 20 mm, mice were sacrificed and analyzed for tumor metastasis. Alcohol
consumption significantly increased the metastases in the lung and colon. B: After alcohol
exposure, the mammary tumor tissues were assessed for the expression of phosphorylated
ErbB2 (pErbB2) and p38γ MAPK (p-p38γ) by immunoblotting. The relative levels of
pErbB2 and p-p38γ were quantified and normalized to the loading control. * denotes
significant difference from control groups (p < 0.05). Alcohol consumption significantly
increased the phosphorylation of ErbB2 and p38γ ([33].
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Alcohol increases the cancer stem-like cell (CSC) population. A: Human breast cancer cell
lines MCF7 or MCF7 overexpressing ErbB2 cells (MCF7-ErbB2) were exposed to alcohol
(0 or 100 mg/dl) for 10 days, and then evaluated for CSCs by the ALDEFLUOR assay. *
denotes significant difference from respective control groups. # denotes significant
difference from alcohol-treated MCF7 cells. B: MCF7-ErbB2 cells were exposed to alcohol
(0, 100 mg/dl) for 10 days and then mammosphere formation was evaluated under the
microscope. C: MCF7, MCF7-ErbB2 or BT474 cells were exposed to alcohol (0, 100
mg/dl) for 10 days. The number of mammospheres was determined. * denotes significant
difference from respective control groups. # denotes significant difference from alcoholtreated MCF7 cells. D: FVB MMTV Neu mice were fed with a liquid diet containing
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ethanol (0 or 6.7%). After alcohol exposure, the mammary tumor tissues were assessed for
the expression of CD44. * denotes significant difference from respective control groups.
Alcohol significantly increased CSC population in vitro and in vivo [33].
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Figure 3.
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Alcohol stimulates the phosphorylation of ErbB2, FAK and cSrc. A: MCF7-ErbB2 cells
were pretreated with alcohol for 48 hours and plated to fibronectin-coated coverslips,
allowing attachment for 1 hour. Phosphorylation of FAK (Tyr861) and ErbB2 (Tyr1248) was
detected with immunofluorescent staining. Arrows indicate the co-localization of pErbB2
and pFAK. B: MCF7-ErbB2 cells were pretreated with alcohol for 6–48 hours, and allowed
to attach for 3 hours. Cell lysates were collected and analyzed for the phosphorylation of
FAK and cSrc with immunoblotting. The relative levels of pFAK and pcSrc were quantified
and normalized to the expression of FAK and cSrc, respectively. * denotes significant
difference from respective control groups. Alcohol significantly increased the
phosphorylation of ErbB2, FAK and cSrc [37].
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